Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187499 · ClinicalTrials.gov registry record · NA
Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
NCT00187499 is a NA study that has completed, run by University of California, San Francisco.
The verdict
NCT00187499, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to determine whether an inhaled corticosteroid (fluticasone) alters the expression of any gene expressed in the lining of the airways of asthmatics. The study uses high density gene chips which allow the study investigators to measures all gene in the human genome. We hypothesize that this approach will identify novel genes that are affected by steroids in asthmatics.
Interventions
- DRUG Inhaled fluticasone 500 ug BID for 8 weeks
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-10 |
| Est. Completion | 2005-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187499
The ClinicalTrials.gov registry entry for NCT00187499 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled fluticasone 500 ug BID for 8 weeks is the first listed.
NCT00187499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187499 about?
NCT00187499 is a clinical study titled "Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma". The purpose of this study is to determine whether an inhaled corticosteroid (fluticasone) alters the expression of any gene expressed in the lining of the airways of asthmatics. The study uses high density gene chips which allow the study investigators to measures all gene in the human genome. We hy...
What is the current status of trial NCT00187499?
This trial is currently completed. It is a NA study. The study started on 2002-10. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00187499?
The interventions under investigation include: Inhaled fluticasone 500 ug BID for 8 weeks (DRUG).
Who is sponsoring clinical trial NCT00187499?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.